0
0
WASHINGTON, D.C.—In a narrowly split vote on Tuesday, the U.S. Senate confirmed Susan Monarez as the new director of the Centers for Disease Control and Prevention (CDC), making her the first director in over 70 years without a medical degree and the first to require Senate approval under a 2023 law. The 51-47 party-line vote installs President Donald Trump’s nominee at the helm of an agency facing deep budget cuts, leadership turmoil, and controversy over vaccine policy.
A veteran government scientist with a Ph.D. in microbiology and immunology, Monarez most recently served as acting CDC director and, prior to that, as deputy director of the Advanced Research Projects Agency for Health. Her confirmation follows Trump’s withdrawal of his previous nominee, Dr. David Weldon, whose controversial views on vaccine safety drew bipartisan criticism.
A New Kind of Leader for the CDC
Monarez’s rise to the nation’s top public health post comes as the CDC confronts staff departures, program cuts, and proposed budget reductions nearing 50% by 2026. The Trump administration—led in public health by Health and Human Services Secretary Robert F. Kennedy Jr.—has also been sharply criticized by doctors and public health advocates for dismissing CDC advisory committees and altering long-standing vaccine guidelines.
During her Senate confirmation hearing, Monarez pledged to restore trust and credibility in the CDC, emphasizing transparent leadership and science-based public health recommendations. She stated, “Vaccines absolutely save lives, and if I’m confirmed as CDC director, I commit to making sure we continue to prioritize vaccine availability.” Monarez also voiced support for the continued use of fluoride in drinking water for oral health, another point of contention with Secretary Kennedy.
Despite her commitment to science and evidence-based policy, Monarez was pressed by lawmakers—especially Democrats—on how she would navigate administrative directives that contradict scientific consensus. “If I’m confirmed as CDC director, I look forward to supporting the secretary with science and evidence, and making sure that I am giving him the best information possible,” she told the Senate.
Challenges Await
Morale within the CDC has reportedly sunk as the agency has lost roughly one-third of its workforce since January. Many key public health programs targeting chronic diseases and mental health are expected to be reassigned to other HHS divisions as part of an ongoing restructuring effort. Observers say Monarez will need to balance her reputation as an independent, data-driven leader against the Trump administration’s push to overhaul the agency’s scope and policies.
Senate Health Committee Chair Bill Cassidy (R-La.) lauded her appointment, asserting the nation “needs a CDC leader who makes decisions rooted in science.” Meanwhile, Democratic senators expressed concern Monarez might face pressure not to challenge political directives. Senator Bernie Sanders (I-Vermont), who opposed her nomination, argued the CDC demands a director “who will defend science, protect public health, and repudiate conspiracy theories about safe and effective vaccines”.
Looking Forward
As she assumes her role as CDC director, Monarez is inheriting both a wounded agency and a nation still reckoning with public health crises. In a statement after the confirmation, she said her priorities would be “to restore public trust, strengthen science-based leadership at the CDC, and ensure that the agency is positioned to respond rapidly and effectively to outbreaks and other health emergencies”.
Disclaimer:
This news article is based on information available from public press reports and official statements as of July 31, 2025. Developments may evolve as new information emerges.
